Is Cytotron FDA approved?
The FDA recognizes the Cytotron as a Breakthrough Device for the treatment of Breast, Pancreas and Liver Cancers, by conducting a clinical trial to establish that it is better than existing standards of care for these indications.
What is the use of Cytotron?
Cytotron is intended to cause degeneration of uncontrolled growth of tissues. “It is indicated for treating protein-linked, abnormally regenerating disorders such as neoplastic disease, and allowing extended progression free survival, with pain relief, palliation, improved quality and dignity of life,” says the letter.
Is Cytotron available in India?
In India, this machine is not yet available, although they claim to give treatment to people at their centre. “In India, the Cytotron will cost anywhere between Rs 2.5 to Rs 3 crore,” says Dr Kumar.
What is Rfqmr?
Rotational Field Quantum Magnetic Resonance (RFQMR) is a technology that is made to deliver highly complex quantum electromagnetic beams in the sub-radio and near-radio frequency spectrum.
Who invented the Cytotron?
The CYTOTRON is a novel, patented therapeutic device, invented by Dr. Rajah Vijay Kumar and his team at Centre for Advanced Research and Development (CARD), the R&D wing of Scalene Cybernetics Limited, an Indian Technology company.
Is Erleada a biologic?
Apalutamide is an antiandrogen, and acts as an antagonist of the androgen receptor, the biological target of androgens like testosterone and dihydrotestosterone….Apalutamide.
| Clinical data | |
|---|---|
| License data | US DailyMed: Erleada |
| Pregnancy category | AU : D |
| Routes of administration | By mouth |
| Drug class | Nonsteroidal antiandrogen |
What is Rotational Field Quantum Magnetic Resonance Therapy?
Generically known as Rotational Field Quantum Nuclear Magnetic Resonance (RFQMR), it is a technology that is made to deliver highly complex quantum instantaneous Nuclear Magnetic Resonance beams in the RF bands and its harmonics ranging from 3KHz to 300 MHz with a near field delivery using specialized antenna in the …
Is Erleada a hormone therapy?
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant).
What is the cost of Apalutamide?
Apalutamide is used to treat men with prostate cancer. Learn more about this drug here. This is a brand name drug and a generic may be available. The average cost for 120 Tablet(s), 60mg each, is $14,697.69.
What are the side effects of Erleada?
ERLEADA® may cause serious side effects including:
- chest pain or discomfort at rest or with activity.
- shortness of breath.
- numbness or weakness of the face, arm, or leg, especially on one side of the body.
- trouble talking or understanding.
- trouble seeing in one or both eyes.
When is the best time to take Erleada?
Take your prescribed dose of ERLEADA® 1 time a day, at the same time each day. Take ERLEADA® with or without food. Swallow ERLEADA® tablets whole. If you miss a dose of ERLEADA®, take your normal dose as soon as possible on the same day.
How long is Erleada effective?
The TITAN final analysis data, recently published in the Journal of Clinical Oncology, found adding Erleada to ADT continued to provide statistically significant OS benefit after 44 months in patients with mCSPC and reduced the risk of death by 35 percent compared with ADT alone.
What is cytotron ® treatment?
Essentially, the Cytotron ® treatment helps to re-generate cells and/or to stop the uncontrolled growth of cells. Clinical experience shows that it is particularly effective for cancer and for arthritis. In conventional cancer treatment, chemo/radiation therapies physically destroy cancer cells to arrest tumour growth.
Where is cycytotron ® available?
Cytotron ® is already available in countries like Malaysia, Netherlands, Saudi Arabia and Pakistan. The device will be available in Canada, Hungary and in the US in the near future. The US Treasury has recently announced a generous grant for clinical trials in the US.
Is cytotron India’s latest biomedical breakthrough?
Till recently, India could hardly boast of any such biomedical breakthrough technology. But, after several years of research, development and speculation, the indigenously developed cutting-edge non-invasive cancer treatment device, Cytotron, has finally arrived.
Can the cytotron be used to treat cancer and osteoarthritis?
With the Cytotron now being recognized and accepted as one of the therapeutic modality with the grant of the EU certification, there has been a widespread interest in the technology for the treatment of cancer and osteoarthritis.